Fill out the fields below to share information with your colleagues.

Fields marked with an (*) are required.


Subject: Information about confronting the deadly threat of prostate cancer in the bone

E-mail addresses will be used solely to send this information. Bayer will not retain or sell e-mail addresses or personal information.

References: 1. Nørgaard M, Jensen AØ, Jacobsen JB, Cetin K, Fryzek JP, Sørensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010;184(1):162-167. 2. Gandaglia G, Karakiewicz PI, Briganti A, et al. Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur Urol. 2015;68(2):325-334. 3. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther. 2007;6(10):2609-2617. 4. Bagi CM. Skeletal implications of prostate cancer. J Musculoskelet Neuronal Interact. 2003;3(2):112-117. 5. Gundem G, Van Loo P, Kremeyer B, et al; ICGC Prostate UK Group. The evolutionary history of lethal metastatic prostate cancer. Nature. 2015;520(7547):353-357.